Masimo (MASI) Reports Encouraging 2020 Preliminary Results
Per the preliminary announcement, Masimo (MASI) projects 2020 product revenues to improve.
Zacks · 2h ago
Integra (IART) Preliminary Q4 Reported Sales Show Recovery
Integra's (IART) sales improvement in the fourth quarter is likely to have been boosted by on-going business recovery.
Zacks · 4h ago
Exact Sciences (EXAS) Posts Solid Preliminary Q4 Testing Revenues
Exact Sciences' (EXAS) strength in Screening revenue along with a robust COVID-19 testing arm are likely to have boosted the top line significantly.
Zacks · 1d ago
BD (BDX) Posts Upbeat Preliminary Fiscal First Quarter Results
BD (BDX) projects its fiscal Q1 revenues to surge from the year-ago figure, primarily on the back of high demand for its COVID-19 diagnostic tests
Zacks · 1d ago
Intuitive Surgical (ISRG) Up on Solid Preliminary Q4 Results
Zacks · 1d ago
Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues
Zacks · 2d ago
Here's Why You Should Invest in McKesson (MCK) Stock Now
Zacks · 2d ago
DexCom (DXCM) Posts Solid Preliminary Q4 and 2020 Revenues
DexCom (DXCM) posts solid fourth-quarter and full-year 2020 revenue data on the back of resilience shown in the face of the COVID-19 induced challenges.
Zacks · 2d ago featured highlights include: IDEXX Laboratories, AGCO, D.R. Horton and MSCI
Zacks · 2d ago
Nevro (NVRO) Posts Weak Preliminary Q4 and 2020 Revenues
Nevro's (NVRO) preliminary worldwide Q4 revenues are expected to decline from the year-ago quarter's figure.
Zacks · 3d ago
Phirbo (PAHC) Nutritional Specialty Aids Growth, Low ASP Ails
Phirbo's (PAHC) net vaccine sales remain robust on higher international demand for poultry vaccines.
Zacks · 3d ago
AMN Healthcare (AMN) Releases Solid Preliminary Q4 Revenues
Zacks · 3d ago
4 of the Best Stocks to Buy for Solid Earnings Growth in 2021
Earnings growth is considered the most important variable in influencing the share price. Notably, some of the stocks that boast of superb earnings growth include D.R. Horton (DHI) and MSCI.
Zacks · 3d ago
Poultry Diagnostics Market 2021 Research Report by Experts – Zoetis, QIAGEN, IDvet, BioChek Smart Veterinary Diagnostics
Jan 12, 2021 (Market Insight Reports) -- "COVID-19 Impact on Poultry Diagnostics Market, Global Research Reports 2020-2021" The New report includes a...
Market Insight Reports · 3d ago
31.8% Return Seen to Date on SmarTrend Idexx Labs Call (IDXX)
SmarTrend identified an Uptrend for Idexx Labs (NASDAQ:IDXX) on September 28th, 2020 at $383.92. In approximately 4 months, Idexx Labs has returned 31.83% as of today's recent price of $506.13.
Comtex SmarTrend(R) · 3d ago
Henry Schein Inc. stock rises Monday, outperforms market
Shares of Henry Schein Inc. inched 0.39% higher to $72.38 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P... · 3d ago
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors
Shares of IDEXX Laboratories Inc. slipped 1.30% to $506.55 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P... · 3d ago
IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
, /PRNewswire/ -- (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 fourth quarter and full-year financial results for before the market opens. The Company will conduct an analyst conference call beginning at on that day.
PR Newswire - PRF · 3d ago
Here’s Why Red-Hot ZOM Stock Could Soar Another 200%
Zomedica's TRUFORMA platform could disrupt the $2.8 billion vet diagnostics market and propel ZOM stock above $3. · 4d ago
Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio
Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.
Zacks · 4d ago
Webull provides a variety of real-time IDXX stock news. You can receive the latest news about IDEXX Labs through multiple platforms. This information may help you make smarter investment decisions.
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include diagnostic and information technology-based products and services for the veterinary market, which the Company refers to as the Companion Animal Group; water quality products; diagnostic products and services for livestock and poultry health, which the Company refers to as Livestock, Poultry and Dairy, and Other operating segment, which combines and presents products for the human point-of-care medical diagnostics market with its pharmaceutical product line and its out-licensing arrangements. Its products and services include point-of-care veterinary diagnostic products, comprising instruments, consumables and rapid assay test kits, among others.